Posterior ocular manifestations following BNT162b2 mRNA COVID-19 vaccine: a case series

PURPOSE: To report the occurrence of posterior ocular adverse events following the administration of the BNT162b2 mRNA vaccine against SARS-CoV-2. METHODS: A retrospective consecutive case series, in which the medical files of patients presenting with ocular adverse events within 30 days of the vacc...

Descripción completa

Detalles Bibliográficos
Autores principales: Pillar, Shani, Weinberg, Tamar, Amer, Radgonde
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628305/
https://www.ncbi.nlm.nih.gov/pubmed/36316618
http://dx.doi.org/10.1007/s10792-022-02565-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628305/
https://www.ncbi.nlm.nih.gov/pubmed/36316618
http://dx.doi.org/10.1007/s10792-022-02565-2

Ejemplares similares